0001554795-17-000389.txt : 20171109 0001554795-17-000389.hdr.sgml : 20171109 20171109133423 ACCESSION NUMBER: 0001554795-17-000389 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 25 CONFORMED PERIOD OF REPORT: 20170930 FILED AS OF DATE: 20171109 DATE AS OF CHANGE: 20171109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CANCER CAPITAL CORP CENTRAL INDEX KEY: 0001130889 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 911803648 STATE OF INCORPORATION: WY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-32363 FILM NUMBER: 171189965 BUSINESS ADDRESS: STREET 1: 2157 S. LINCOLN STREET 2: 2157 S. LINCOLN CITY: SALT LAKE CITY STATE: UT ZIP: 84106 BUSINESS PHONE: 8013232395 MAIL ADDRESS: STREET 1: 2157 S. LINCOLN STREET 2: 2157 S. LINCOLN CITY: SALT LAKE CITY STATE: UT ZIP: 84106 10-Q 1 cncl1026form10q.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☑QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2017

 

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___ to ___

 

Commission file number: 000-32363

 

CANCER CAPITAL CORP.

(Exact name of registrant as specified in its charter)

 

Wyoming

(State or other jurisdiction of incorporation or organization)

91-1803648

(I.R.S. Employer Identification No.)

2157 S. Lincoln Street, Salt Lake City, Utah

(Address of principal executive offices)

84106

(Zip code)

 

(801) 323-2395

(Registrant’s telephone number, including area code)

 

The registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☑ No ☐ The registrant does not have a Web site.

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐

Non-accelerated filer ☐

Emerging growth company ☑

Accelerated filer ☐

Smaller reporting company ☑

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☑ No ☐

 

The number of shares outstanding of the registrant’s common stock as of November 3, 2017 was 6,150,000.

 
 

TABLE OF CONTENTS

 

  PART I – FINANCIAL INFORMATION  
     
Item 1. Financial Statements (Unaudited) 2
Condensed Balance Sheets (Unaudited) 3
  Condensed Statements of Operations (Unaudited) 4
  Condensed Statements of Cash Flows (Unaudited) 5
  Condensed Notes to the Unaudited Financial Statements 6
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 7
Item 3. Quantitative and Qualitative Disclosures about Market Risk 9
Item 4. Controls and Procedures 9
     
  PART II – OTHER INFORMATION  
     
Item 6. Exhibits 10
Signature 11

 

 

 

 

 

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

 

 

CANCER CAPITAL CORP.

 

Condensed Financial Statements

 

September 30, 2017

 

(Unaudited)

 

 2 

 

Cancer Capital Corp.

Condensed Balance Sheets

(Unaudited)

 

       
  

SEPT 30,

2017

 

DEC 31,

2016

       
       
ASSETS          
CURRENT ASSETS          
Cash  $425   $625 
Total current assets   425    625 
Total assets  $425   $625 
           
LIABILITIES AND STOCKHOLDERS' DEFICIT          
CURRENT LIABILITIES          
Accounts payable - related party  $12,000   $6,900 
Notes payable – related party   92,625    91,625 
Notes payable   82,575    78,075 
Accrued interest – related party   24,757    19,250 
Accrued interest   25,956    21,143 
Total current liabilities   237,913    216,993 
Total liabilities   237,913    216,993 
           
STOCKHOLDERS' DEFICIT          
Common stock, $.001 par value; 20,000,000 shares authorized; 6,150,000 shares issued and outstanding   6,150    6,150 
Additional paid-in capital   47,050    47,050 
Accumulated deficit   (290,688)   (269,568)
Total stockholders' deficit   (237,488)   (216,368)
Total liabilities and stockholders' deficit  $425   $625 

 

 

The accompanying notes are an integral part of these financial statements.

 

 3 

 

Cancer Capital Corp.

Condensed Statements of Operations

(Unaudited)

 

             
   FOR THE
THREE
MONTHS
ENDED
SEPT 30,
2017		  FOR THE
THREE
MONTHS
ENDED
SEPT 30,
2016		  FOR THE
NINE
MONTHS
ENDED
SEPT 30,
2017		  FOR THE
NINE
MONTHS
ENDED
SEPT 30,
2016
             
Revenues  $—     $—     $—     $—   
             
Expenses                    
General and administrative   2,600    2,700    10,800    11,173 
Total expenses   2,600    2,700    10,800    11,173 
                     
Loss from operations before other expense   (2,600)   (2,700)   (10,800)   (11,173)
                     
Other income (expense) non-operating                    
Interest expense – related party   (1,842)   (1,665)   (5,507)   (4,995)
Interest expense   (1,651)   (1,546)   (4,813)   (4,468)
Total other expense   (3,493)   (3,211)   (10,320)   (9,463)
                     
                     
Loss from operations before taxes   (6,093)   (5,911)   (21,120)   (20,636)
                     
Taxes   —      —      —      —   
                     
Net loss  $(6,093)  $(5,911)  $(21,120)  $(20,636)
                     
Net loss per share  $(0.00)  $(0.00)  $(0.00)  $(0.00)
                     
Weighted average shares outstanding   6,150,000    6,150,000    6,150,000    6,150,000 

 

  

The accompanying notes are an integral part of these financial statements.

 

 4 

 

Cancer Capital Corp.

Condensed Statements of Cash Flows

(Unaudited)

 

       
   FOR THE NINE MONTHS
ENDED
SEPT 30,
2017		  FOR THE NINE MONTHS
ENDED
SEPT 30,
2016
       
Cash Flows from Operating Activities          
Net Loss  $(21,120)  $(20,636)
Adjustment to reconcile net loss to cash provided (used) by operating activities:          
Expenses paid by related party   5,100    5,300 
Changes in operating assets and liabilities:          
Accrued interest – related party   5,507    4,995 
Accrued interest   4,813    4,468 
Net cash provided (used) by operating activities   (5,700)   (5,873)
           
Cash Flows from Investing Activities          
Net cash provided by investing activities   —      —   
           
Cash Flows from Financing Activities          
Proceeds from advances and notes payable - related party   1,000    —   
Proceeds from advances and notes payable   4,500    7,000 
Net cash provided by financing activities   5,500    7,000 
           
Increase (decrease) in cash   (200)   1,127 
           
Cash and cash equivalents at beginning of year   625    598 
           
Cash and cash equivalents at end of year  $425   $1,725 

 

 

The accompanying notes are an integral part of these financial statements.

 

 5 

 

Cancer Capital Corp.

Notes to the Condensed Financial Statements

(Unaudited)

September 30, 2017

 

 

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION

 

The accompanying unaudited condensed financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted in accordance with such rules and regulations. The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim condensed financial statements be read in conjunction with the Company’s audited financial statements and notes thereto included in its December 31, 2016 Annual Report on Form 10-K. Operating results for the nine months ended September 30, 2017 are not necessarily indicative of the results to be expected for year ending December 31, 2017.

 

 

NOTE 2 – GOING CONCERN

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has limited assets, has incurred losses since inception, has negative cash flows from operations, and has no revenue-generating activities. Its activities have been limited for the past several years and it is dependent upon financing to continue operations. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. It is management’s plan to acquire or merge with other operating companies. 

 

NOTE 3 – NOTES PAYABLE

 

During the nine months ended September 30, 2017, the Company borrowed $1,000 from a related party and $4,500 from third parties. These loans are due on demand and bear interest at the rate of 8%.

 

NOTE 4 – SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and has determined that there are no such events that would have a material impact on the financial statements.

 

 6 

 

 

In this report references to “Cancer Capital,” “the Company,” “we,” “us,” and “our” refer to Cancer Capital Corp.

 

FORWARD LOOKING STATEMENTS

 

The Securities and Exchange Commission (“SEC”) encourages companies to disclose forward-looking information so that investors can better understand future prospects and make informed investment decisions. This report contains these types of statements. Words such as “may,” “intend,” “expect,” “believe,” “anticipate,” “estimate,” “project,” or “continue” or comparable terminology used in connection with any discussion of future operating results or financial performance identify forward-looking statements. You are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this report. All forward-looking statements reflect our present expectation of future events and are subject to a number of important factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Executive Overview

 

We have not recorded revenues for the past two fiscal years and we are dependent upon financing to continue basic operations. Management intends to rely upon advances or loans from management, significant stockholders or third parties to meet our cash requirements, but we have not entered into written agreements guaranteeing funds and, therefore, no one is obligated to provide funds to us in the future. These factors raise doubt as to our ability to continue as a going concern. Our plan is to combine with an operating company to generate revenue.

 

As of the date of this report, our management has not had any discussions with any representative of any other entity regarding a business combination with us. Any target business that is selected may be a financially unstable company or an entity in its early stages of development or growth, including entities without established records of sales or earnings. In that event, we will be subject to numerous risks inherent in the business and operations of financially unstable and early stage or potential emerging growth companies. In addition, we may effect a business combination with an entity in an industry characterized by a high level of risk, and, although our management will endeavor to evaluate the risks inherent in a particular target business, there can be no assurance that we will properly ascertain or assess all significant risks. In addition, any business combination or transaction will likely result in a significant issuance of shares and substantial dilution to present stockholders of the Company.

 

We anticipate that the selection of a business opportunity will be complex and extremely risky. Because of general economic conditions, rapid technological advances being made in some industries and shortages of available capital, our management believes that there are numerous firms seeking the perceived benefits of becoming a publicly traded corporation. Such perceived benefits of becoming a publicly traded corporation include, among other things, facilitating or improving the terms on which additional equity financing may be obtained, providing liquidity for the principals of and investors in a business, creating a means for providing incentive stock options or similar benefits to key employees, and offering greater flexibility in structuring acquisitions, joint ventures and the like through the issuance of securities. Potentially available business combinations may occur in many different industries and at various stages of development, all of which will make the task of comparative investigation and analysis of such business opportunities extremely difficult and complex.

 

If we obtain a business opportunity, then it may be necessary to raise additional capital. We anticipate that we will sell our common stock to raise this additional capital. We expect that we would issue such stock pursuant to exemptions to the registration requirements provided by federal and state securities laws. The purchasers and manner of issuance will be determined according to our financial needs and the available exemptions to the registration requirements of the Securities Act of 1933. We do not currently intend to make a public offering of our stock. We also note that if we issue more shares of our common stock, then our stockholders may experience dilution in the value per share of their common stock.

 

Liquidity and Capital Resources

 

We have not recorded revenues from operations since inception and we have not established an ongoing source of revenue sufficient to cover our operating costs. We have relied primarily upon related and third parties to provide and pay for professional and operational expenses. At September 30, 2017 we had $425 cash compared to $625 at December 31, 2016. At September 30, 2017 total liabilities increased to $237,913 compared to $216,993 at December 31, 2016. This increase in total liabilities primarily represents cash advances, an increase in notes payable, accrued interest and accounts payable for consulting services and professional services provided by or paid for by a stockholder and third parties.

 

We intend to obtain capital from management, significant stockholders and/or third parties to cover minimal operations; however, there is no assurance that additional funding will be available. Our ability to continue as a going concern during the long term is dependent upon our ability to find a suitable business opportunity and acquire or enter into a merger with such company. The type of business opportunity with which we acquire or merge will affect our profitability for the long term.

 

During the next 12 months we anticipate incurring additional costs related to the filing of Exchange Act reports. We believe we will be able to meet these costs through funds provided by management, significant stockholders and/or third parties. We may also rely on the issuance of our common stock in lieu of cash to convert debt or pay for expenses.

 

 7 

 

Results of Operations

 

We did not record revenues in either 2017 or 2016. General and administrative expense decreased to $10,800 for the nine months ended September 30, 2017 (“2017 nine month period”) compared to $11,173 for the nine months ended September 30, 2016 (“2016 nine month period”). General and administrative expense decreased to $2,600 for the three months ended September 30, 2017 (“2017 third quarter”) compared to $2,700 for the three months ended September 30, 2016 (“2016 third quarter”).

 

Total other expense increased to $10,320 for the 2017 nine month period compared to $9,463 for the 2016 nine month period and increased to $3,493 for the 2017 third quarter compared to $3,211 for the 2016 third quarter. Total other expense represents accrued interest related to notes payable.

 

Our net loss increased to $21,120 for the 2017 nine month period compared to $20,636 for the 2016 nine month period and increased to $6,093 for the 2017 third quarter compared to $5,911 for the 2016 third quarter. Management expects net losses to continue until we acquire or merge with a business opportunity.

 

Commitments and Obligations

 

At September 30, 2017 we recorded notes payable totaling $82,575 and notes payable-related party of $92,625. All of the notes payable are non-collateralized, carry interest at 8% and are due on demand. Total accrued interest as of September 30, 2017 on all notes payable was $50,713.

 

At September 30, 2017 accounts payable increased to $12,000. During the 2017 nine month period a stockholder provided or paid for consulting services and professional services totaling $5,100.

 

During the nine months ended September 30, 2017, the Company received advances of $4,500 from a third party and $1,000 from a related party. Interest expense for the $5,500 for the nine months ended September 30, 2017 was $253.

 

As of September 30, 2017, two lenders represent in excess of 95% of our accounts and notes payable.

 

Off-Balance Sheet Arrangements

 

We have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors.

 

Critical Accounting Policies

 

We qualify as an “emerging growth company” under the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). As a result, we are permitted to, and intend to, rely on exemptions from certain disclosure requirements. For so long as we are an emerging growth company, among other things, we will not be required to:

 

•Have an auditor report on our internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act;

 

•Submit certain executive compensation matters to shareholder advisory votes, such as “say-on-pay” and “say-on-frequency”

 

•Obtain shareholder approval of any golden parachute payments not previously approved; and

 

•Disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the Chief Executives compensation to median employee compensation.

 

In addition, Section 107 of the JOBS Act also provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of the benefits of this extended transition period. Our financial statements may therefore not be comparable to those of companies that comply with such new or revised accounting standards.

 

We will remain an “emerging growth company” for up to five years, or until the earliest of (i) the last day of the first fiscal year in which our total annual gross revenues exceed $1 billion; (ii) the date that we become a “large accelerated filer” as defined in Rule 12b-2 under the Securities Exchange Act of 1934, which would occur if the market value of our ordinary shares that is held by non-affiliates exceeds $700 million as of the last business day of our most recently completed third fiscal quarter or (iii) the date on which we have issued more than $1 billion in non-convertible debt during the preceding three-year period.

 

 8 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable to smaller reporting companies.

 

 

ITEM 4. CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed in our filings under the Exchange Act is recorded, processed, summarized and reported within the periods specified in the rules and forms of the SEC. This information is accumulated to allow our management to make timely decisions regarding required disclosure. Our President, who serves as our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report and he determined that our disclosure controls and procedures were ineffective due to a control deficiency. During the period we did not have additional personnel to allow segregation of duties to ensure the completeness or accuracy of our information. Due to the size and operations of the Company we are unable to remediate this deficiency until we acquire or merge with another company.

 

Changes to Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Management conducted an evaluation of our internal control over financial reporting and determined that there were no changes made in our internal control over financial reporting during the quarter ended September 30, 2017 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting. 

 

 9 

 

PART II – OTHER INFORMATION

 

ITEM 6. EXHIBITS

 

Part I Exhibits

No. Description
31.1 Principal Executive Officer Certification
31.2 Principal Financial Officer Certification
32.1 Section 1350 Certification

 

Part II Exhibits

No.    Description
3(i)

Wyoming Articles of Domestication for Cancer Capital, dated April 28, 2016 (Incorporated by reference to exhibit 3(i) to Form 10-Q, filed May 13, 2016)

3(ii)

Bylaws of Cancer Capital, dated May 2, 2016 (Incorporated by reference to exhibit 3(ii) to Form 10-Q, filed May 13, 2016)

101.INS XBRL Instance Document
101.SCH XBRL Taxonomy Extension Schema Document
101.CAL XBRL Taxonomy Calculation Linkbase Document
101.CAL XBRL Taxonomy Extension Definition Linkbase Document
101.LAB XBRL Taxonomy Label Linkbase Document
101.PRE XBRL Taxonomy Presentation Linkbase Document

 

 10 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Date: November 9, 2017

CANCER CAPITAL CORP.

 

By : /s/ John W. Peters          

John W. Peters

President and Director

Principal Financial Officer

 

 

11

 EX-31.1 2 cncl1026form10qexh31_1.htm EXHIBIT 31.1

Exhibit 31.1

 

PRINCIPAL EXECUTIVE OFFICER CERTIFICATION

 

I, John W. Peters, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Cancer Capital Corp.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statement made, in light of the circumstances under which statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: November 9, 2017

 

/s/ John W. Peters          

John W. Peters

Principal Executive Officer

 EX-31.2 3 cncl1026form10qexh31_2.htm EXHIBIT 31.2

Exhibit 31.2

 

PRINCIPAL FINANCIAL OFFICER CERTIFICATION

 

I, John W. Peters, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of Cancer Capital Corp.;

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statement made, in light of the circumstances under which statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

 

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: November 9, 2017

 

/s/ John W. Peters          

John W. Peters

Principal Financial Officer

 EX-32.1 4 cncl1026form10qexh32_1.htm EXHIBIT 32.1

Exhibit 32.1

 

 

CANCER CAPITAL CORP.

 

CERTIFICATION OF PERIODIC REPORT

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

18 U.S.C. Section 1350

 

The undersigned executive officer of Cancer Capital Corp. certifies pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:

 

a.the quarterly report on Form 10-Q of Cancer Capital Corp. for the quarter ended September 30, 2017 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

b.the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Cancer Capital Corp.

 

 

 

Date: November 9, 2017

 

 

/s/ John W. Peters          

John W. Peters

Principal Executive Officer

Principal Financial Officer

 EX-101.INS 5 cncl-20170930.xml XBRL INSTANCE FILE 0001130889 2017-01-01 2017-09-30 0001130889 2017-11-03 0001130889 2017-09-30 0001130889 2016-12-31 0001130889 2017-07-01 2017-09-30 0001130889 2016-07-01 2016-09-30 0001130889 2016-01-01 2016-09-30 0001130889 2015-12-31 0001130889 2016-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure CANCER CAPITAL CORP 0001130889 10-Q 2017-09-30 false --12-31 No No Yes Smaller Reporting Company Q3 2017 6150000 425 625 598 1725 425 625 425 625 12000 6900 92625 91625 82575 78075 24757 19250 25956 21143 237913 216993 237913 216993 6150 6150 47050 47050 -237488 -216368 425 625 0.001 0.001 20000000 20000000 6150000 6150000 6150000 6150000 10800 2600 2700 11173 10800 2600 2700 11173 -10800 -2600 -2700 -11173 5507 1842 1665 4995 4813 1651 1546 4468 10320 3493 3211 9463 -21120 -6093 -5911 -20636 -21120 -6093 -5911 -20636 0.00 0.00 0.00 0.00 6150000 6150000 6150000 6150000 5100 5300 5507 4995 4813 4468 -5700 -5873 4500 7000 5500 7000 -200 1127 <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-size: 11pt">NOTE 1 -&#9;BASIS OF FINANCIAL STATEMENT PRESENTATION</font></p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: -0.75in">&#160;</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.75in; text-align: justify; text-indent: 0in">The accompanying unaudited condensed financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted in accordance with such rules and regulations. The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim condensed financial statements be read in conjunction with the Company&#8217;s audited financial statements and notes thereto included in its December 31, 2016 Annual Report on Form 10-K. Operating results for the nine months ended September 30, 2017 are not necessarily indicative of the results to be expected for year ending December 31, 2017.</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 4 &#8211; SUBSEQUENT EVENTS</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.75in; text-align: justify">The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and has determined that there are no such events that would have a material impact on the financial statements.</p> -290688 -269568 <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">NOTE 2 &#8211; GOING CONCERN</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.75in; text-align: justify">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has limited assets, has incurred losses since inception, has negative cash flows from operations, and has no revenue-generating activities. Its activities have been limited for the past several years and it is dependent upon financing to continue operations. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. It is management&#8217;s plan to acquire or merge with other operating companies.</p> 1000 <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">NOTE 3 &#8211; NOTES PAYABLE</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.75in; text-align: justify">During the nine months ended September 30, 2017, the Company borrowed $1,000 from a related party and $4,500 from third parties. These loans are due on demand and bear interest at the rate of 8%.</p> 1000 4500 0.08 EX-101.SCH 6 cncl-20170930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - NOTES PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 cncl-20170930_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 cncl-20170930_def.xml XBRL DEFINITION FILE EX-101.LAB 9 cncl-20170930_lab.xml XBRL LABEL FILE Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash Total current assets Total assets LIABILITIES AND STOCKHOLDERS' DEFICIT CURRENT LIABILITIES Accounts payable - related party Notes payable - related party Notes payable Accrued interest - related party Accrued interest Total current liabilities Total liabilities STOCKHOLDERS' DEFICIT Common stock, $.001 par value; 20,000,000 shares authorized; 6,150,000 shares issued and outstanding Additional paid-in capital Accumulated deficit Total stockholders' deficit Total liabilities and stockholders' deficit Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Expenses General and administrative Total expenses Loss from operations before other expense Other income (expense), non-operating Interest expense - related party Interest expense Total other expense Loss from operations before taxes Taxes Net loss Net loss per share Weighted average shares outstanding Statement of Cash Flows [Abstract] Cash Flows from Operating Activities Net Loss Adjustments to reconcile net loss to cash provided (used) by operating activities: Expenses paid by related party Changes in assets and liabilities: Accrued interest - related party Accrued interest Net cash provided (used) by operating activities Cash Flows from Investing Activities Net cash provided by investing activities Cash Flows from Financing Activities Proceeds from advances and notes payable - related party Proceeds from advances and notes payable Net cash provided by financing activities Increase (decrease) in cash Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Organization, Consolidation and Presentation of Financial Statements [Abstract] BASIS OF FINANCIAL STATEMENT PRESENTATION GOING CONCERN Debt Disclosure [Abstract] NOTES PAYABLE Subsequent Events [Abstract] SUBSEQUENT EVENTS Amounts owed to related party Amounts owed to third parties Interest rate on notes payable Assets, Current Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Costs and Expenses Operating Income (Loss) Interest Expense, Related Party Interest Expense Other Cost and Expense, Operating Income (Loss) from Continuing Operations before Income Taxes, Domestic Increase (Decrease) in Due to Other Related Parties Increase (Decrease) in Interest Payable, Net Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) EX-101.PRE 10 cncl-20170930_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.8.0.1
Document and Entity Information - shares
 9 Months Ended
Sep. 30, 2017
Nov. 03, 2017
Document And Entity Information    
Entity Registrant Name CANCER CAPITAL CORP  
Entity Central Index Key 0001130889  
Document Type 10-Q  
Document Period End Date Sep. 30, 2017  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   6,150,000
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2017  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2017
Dec. 31, 2016
CURRENT ASSETS    
Cash $ 425 $ 625
Total current assets 425 625
Total assets 425 625
CURRENT LIABILITIES    
Accounts payable - related party 12,000 6,900
Notes payable - related party 92,625 91,625
Notes payable 82,575 78,075
Accrued interest - related party 24,757 19,250
Accrued interest 25,956 21,143
Total current liabilities 237,913 216,993
Total liabilities 237,913 216,993
STOCKHOLDERS' DEFICIT    
Common stock, $.001 par value; 20,000,000 shares authorized; 6,150,000 shares issued and outstanding 6,150 6,150
Additional paid-in capital 47,050 47,050
Accumulated deficit (290,688) (269,568)
Total stockholders' deficit (237,488) (216,368)
Total liabilities and stockholders' deficit $ 425 $ 625
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2017
Dec. 31, 2016
Statement of Financial Position [Abstract]    
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 20,000,000 20,000,000
Common stock, shares issued 6,150,000 6,150,000
Common stock, shares outstanding 6,150,000 6,150,000
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Income Statement [Abstract]        
Revenues
Expenses        
General and administrative 2,600 2,700 10,800 11,173
Total expenses 2,600 2,700 10,800 11,173
Loss from operations before other expense (2,600) (2,700) (10,800) (11,173)
Other income (expense), non-operating        
Interest expense - related party (1,842) (1,665) (5,507) (4,995)
Interest expense (1,651) (1,546) (4,813) (4,468)
Total other expense (3,493) (3,211) (10,320) (9,463)
Loss from operations before taxes (6,093) (5,911) (21,120) (20,636)
Taxes
Net loss $ (6,093) $ (5,911) $ (21,120) $ (20,636)
Net loss per share $ 0.00 $ 0.00 $ 0.00 $ 0.00
Weighted average shares outstanding 6,150,000 6,150,000 6,150,000 6,150,000
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash Flows from Operating Activities    
Net Loss $ (21,120) $ (20,636)
Adjustments to reconcile net loss to cash provided (used) by operating activities:    
Expenses paid by related party 5,100 5,300
Changes in assets and liabilities:    
Accrued interest - related party 5,507 4,995
Accrued interest 4,813 4,468
Net cash provided (used) by operating activities (5,700) (5,873)
Cash Flows from Investing Activities    
Net cash provided by investing activities
Cash Flows from Financing Activities    
Proceeds from advances and notes payable - related party 1,000
Proceeds from advances and notes payable 4,500 7,000
Net cash provided by financing activities 5,500 7,000
Increase (decrease) in cash (200) 1,127
Cash and cash equivalents at beginning of period 625 598
Cash and cash equivalents at end of period $ 425 $ 1,725
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
BASIS OF FINANCIAL STATEMENT PRESENTATION
 9 Months Ended
Sep. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
BASIS OF FINANCIAL STATEMENT PRESENTATION

NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION

 

The accompanying unaudited condensed financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted in accordance with such rules and regulations. The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. Although management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested that these interim condensed financial statements be read in conjunction with the Company’s audited financial statements and notes thereto included in its December 31, 2016 Annual Report on Form 10-K. Operating results for the nine months ended September 30, 2017 are not necessarily indicative of the results to be expected for year ending December 31, 2017.
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
GOING CONCERN
 9 Months Ended
Sep. 30, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GOING CONCERN

NOTE 2 – GOING CONCERN

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has limited assets, has incurred losses since inception, has negative cash flows from operations, and has no revenue-generating activities. Its activities have been limited for the past several years and it is dependent upon financing to continue operations. These factors raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. It is management’s plan to acquire or merge with other operating companies.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
NOTES PAYABLE
 9 Months Ended
Sep. 30, 2017
Debt Disclosure [Abstract]  
NOTES PAYABLE

NOTE 3 – NOTES PAYABLE

 

During the nine months ended September 30, 2017, the Company borrowed $1,000 from a related party and $4,500 from third parties. These loans are due on demand and bear interest at the rate of 8%.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
SUBSEQUENT EVENTS
 9 Months Ended
Sep. 30, 2017
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 4 – SUBSEQUENT EVENTS

 

The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued and has determined that there are no such events that would have a material impact on the financial statements.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.8.0.1
NOTES PAYABLE (Details Narrative)
 9 Months Ended
Sep. 30, 2017
USD ($)
Debt Disclosure [Abstract]  
Amounts owed to related party $ 1,000
Amounts owed to third parties $ 4,500
Interest rate on notes payable 8.00%
EXCEL 21 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 23 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 25 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 9 60 1 false 0 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://CNCL/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Balance Sheets (Unaudited) Sheet http://CNCL/role/BalanceSheets Condensed Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Condensed Balance Sheets (Parenthetical) Sheet http://CNCL/role/BalanceSheetsParenthetical Condensed Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Statements of Operations (Unaudited) Sheet http://CNCL/role/StatementsOfOperations Condensed Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Statements of Cash Flows (Unaudited) Sheet http://CNCL/role/StatementsOfCashFlows Condensed Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 00000006 - Disclosure - BASIS OF FINANCIAL STATEMENT PRESENTATION Sheet http://CNCL/role/BasisOfFinancialStatementPresentation BASIS OF FINANCIAL STATEMENT PRESENTATION Notes 6 false false R7.htm 00000007 - Disclosure - GOING CONCERN Sheet http://CNCL/role/GoingConcern GOING CONCERN Notes 7 false false R8.htm 00000008 - Disclosure - NOTES PAYABLE Notes http://CNCL/role/NotesPayable NOTES PAYABLE Notes 8 false false R9.htm 00000009 - Disclosure - SUBSEQUENT EVENTS Sheet http://CNCL/role/SubsequentEvents SUBSEQUENT EVENTS Notes 9 false false R10.htm 00000010 - Disclosure - NOTES PAYABLE (Details Narrative) Notes http://CNCL/role/NotesPayableDetailsNarrative NOTES PAYABLE (Details Narrative) Details http://CNCL/role/NotesPayable 10 false false All Reports Book All Reports cncl-20170930.xml cncl-20170930.xsd cncl-20170930_cal.xml cncl-20170930_def.xml cncl-20170930_lab.xml cncl-20170930_pre.xml http://fasb.org/us-gaap/2017-01-31 http://xbrl.sec.gov/dei/2014-01-31 true true ZIP 27 0001554795-17-000389-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001554795-17-000389-xbrl.zip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